Intervention not reported
Erythropoietin versus placebo: risk of AMS · participants at risk of high altitude illness
It is very uncertain whether the intervention changes erythropoietin versus placebo: risk of AMS (very low certainty).
1 finding from 1 review
- Interventions for preventing high altitude illness: Part 3. Miscellaneous and non‐pharmacological interventions 2019 · Cochrane Headline outcomes onlyRR 0.41 [0.2, 0.84]1 study · 39 participantsVery low